Log In
Print
BCIQ
Print
Print this Print this
 

Loramyc, Oravig, miconazole (BA-001, SO-1105)

Also known as: formerly Lauriad

  Manage Alerts
Collapse Summary General Information
Company Onxeo S.A.
DescriptionMucoadhesive buccal tablet of miconazole
Molecular Target Ergosterol
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCandida
Indication DetailsTreat oropharyngeal candidiasis; Treat oropharyngeal candidiasis in head and neck cancer patients following radiotherapy; Treat oropharyngeal candidiasis in HIV-positive patients; Treat oropharyngeal candidiasis in immunocompromised patients
Regulatory Designation
Partner Dara BioSciences Inc.; Fujifilm Holdings Corp.; Mission Pharmacal Co.; SciClone Pharmaceuticals Inc.; Sosei Group Corp.; Therabel Group S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$246.7M

$11.9M

$113.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today